Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.59 USD | +3.35% | +5.67% | +50.27% |
Business Summary
Number of employees: 385
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines for Cellular Metabolism
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 08/22/08 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 26/22/26 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05/17/05 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/19/01 |
Clive Patience
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/17/01 |
Investor Relations Contact | - | - | |
Charlie Newman
PRN | Corporate Officer/Principal | - | 01/22/01 |
Ellen Lopresti
HRO | Human Resources Officer | - | 01/17/01 |
T. Washburn
AUD | Comptroller/Controller/Auditor | 43 | - |
Tsveta Milanova
PRN | Corporate Officer/Principal | 47 | 03/23/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 01/23/01 |
Director/Board Member | 64 | 09/14/09 | |
May Kin Ho
BRD | Director/Board Member | 71 | 23/15/23 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05/17/05 |
David Scadden
BRD | Director/Board Member | 71 | 27/17/27 |
Brian Goff
CEO | Chief Executive Officer | 55 | 08/22/08 |
Cynthia Smith
BRD | Director/Board Member | 55 | 11/22/11 |
Rahul Ballal
BRD | Director/Board Member | 46 | 11/22/11 |
Catherine Owen
BRD | Director/Board Member | - | 13/23/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 72,989,377 | 55,944,826 ( 76.65 %) | 16,216,411 ( 22.22 %) | 76.65 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.27% | 1.85B | |
-1.85% | 102B | |
+2.36% | 96.09B | |
+2.13% | 22.28B | |
-16.88% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-14.14% | 16.09B | |
+4.84% | 13.83B | |
+33.13% | 11.97B |
- Stock Market
- Equities
- AGIO Stock
- Company Agios Pharmaceuticals, Inc.